Medical Care

Global Invasive Candidiasis Treatment Drug Market Research Report 2025

The global market for Invasive Candidiasis Treatment Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Invasive Candidiasis Treatment Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Invasive Candidiasis Treatment Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Invasive Candidiasis Treatment Drug in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Invasive Candidiasis Treatment Drug include GlaxoSmithKline, Merck & Co., Inc, Pfizer Inc, Cidara Therapeutics, Inc, Astellas Pharma Inc, Gilead Sciences, Inc, Novo Nordisk A/S (Xellia Pharmaceuticals), Biosergen AB, Matinas BioPharma Holdings, Inc, Pulmocide Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Invasive Candidiasis Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Invasive Candidiasis Treatment Drug.
The Invasive Candidiasis Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Invasive Candidiasis Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Invasive Candidiasis Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Merck & Co., Inc
Pfizer Inc
Cidara Therapeutics, Inc
Astellas Pharma Inc
Gilead Sciences, Inc
Novo Nordisk A/S (Xellia Pharmaceuticals)
Biosergen AB
Matinas BioPharma Holdings, Inc
Pulmocide Ltd
F2G Ltd
Segment by Type
Azoles Drug
Echinocandins Drug
Allylamines Drug
Polyenes Drug
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Invasive Candidiasis Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Invasive Candidiasis Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Azoles Drug
1.2.3 Echinocandins Drug
1.2.4 Allylamines Drug
1.2.5 Polyenes Drug
1.2.6 Others
1.3 Market by Application
1.3.1 Global Invasive Candidiasis Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Invasive Candidiasis Treatment Drug Market Perspective (2020-2031)
2.2 Global Invasive Candidiasis Treatment Drug Growth Trends by Region
2.2.1 Global Invasive Candidiasis Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Invasive Candidiasis Treatment Drug Historic Market Size by Region (2020-2025)
2.2.3 Invasive Candidiasis Treatment Drug Forecasted Market Size by Region (2026-2031)
2.3 Invasive Candidiasis Treatment Drug Market Dynamics
2.3.1 Invasive Candidiasis Treatment Drug Industry Trends
2.3.2 Invasive Candidiasis Treatment Drug Market Drivers
2.3.3 Invasive Candidiasis Treatment Drug Market Challenges
2.3.4 Invasive Candidiasis Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Invasive Candidiasis Treatment Drug Players by Revenue
3.1.1 Global Top Invasive Candidiasis Treatment Drug Players by Revenue (2020-2025)
3.1.2 Global Invasive Candidiasis Treatment Drug Revenue Market Share by Players (2020-2025)
3.2 Global Invasive Candidiasis Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Invasive Candidiasis Treatment Drug Revenue
3.4 Global Invasive Candidiasis Treatment Drug Market Concentration Ratio
3.4.1 Global Invasive Candidiasis Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Invasive Candidiasis Treatment Drug Revenue in 2024
3.5 Global Key Players of Invasive Candidiasis Treatment Drug Head office and Area Served
3.6 Global Key Players of Invasive Candidiasis Treatment Drug, Product and Application
3.7 Global Key Players of Invasive Candidiasis Treatment Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Invasive Candidiasis Treatment Drug Breakdown Data by Type
4.1 Global Invasive Candidiasis Treatment Drug Historic Market Size by Type (2020-2025)
4.2 Global Invasive Candidiasis Treatment Drug Forecasted Market Size by Type (2026-2031)
5 Invasive Candidiasis Treatment Drug Breakdown Data by Application
5.1 Global Invasive Candidiasis Treatment Drug Historic Market Size by Application (2020-2025)
5.2 Global Invasive Candidiasis Treatment Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Invasive Candidiasis Treatment Drug Market Size (2020-2031)
6.2 North America Invasive Candidiasis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025)
6.4 North America Invasive Candidiasis Treatment Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Invasive Candidiasis Treatment Drug Market Size (2020-2031)
7.2 Europe Invasive Candidiasis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025)
7.4 Europe Invasive Candidiasis Treatment Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Invasive Candidiasis Treatment Drug Market Size (2020-2031)
8.2 Asia-Pacific Invasive Candidiasis Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Invasive Candidiasis Treatment Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Invasive Candidiasis Treatment Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Invasive Candidiasis Treatment Drug Market Size (2020-2031)
9.2 Latin America Invasive Candidiasis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025)
9.4 Latin America Invasive Candidiasis Treatment Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Invasive Candidiasis Treatment Drug Market Size (2020-2031)
10.2 Middle East & Africa Invasive Candidiasis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Invasive Candidiasis Treatment Drug Introduction
11.1.4 GlaxoSmithKline Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025)
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck & Co., Inc
11.2.1 Merck & Co., Inc Company Details
11.2.2 Merck & Co., Inc Business Overview
11.2.3 Merck & Co., Inc Invasive Candidiasis Treatment Drug Introduction
11.2.4 Merck & Co., Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025)
11.2.5 Merck & Co., Inc Recent Development
11.3 Pfizer Inc
11.3.1 Pfizer Inc Company Details
11.3.2 Pfizer Inc Business Overview
11.3.3 Pfizer Inc Invasive Candidiasis Treatment Drug Introduction
11.3.4 Pfizer Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025)
11.3.5 Pfizer Inc Recent Development
11.4 Cidara Therapeutics, Inc
11.4.1 Cidara Therapeutics, Inc Company Details
11.4.2 Cidara Therapeutics, Inc Business Overview
11.4.3 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Introduction
11.4.4 Cidara Therapeutics, Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025)
11.4.5 Cidara Therapeutics, Inc Recent Development
11.5 Astellas Pharma Inc
11.5.1 Astellas Pharma Inc Company Details
11.5.2 Astellas Pharma Inc Business Overview
11.5.3 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Introduction
11.5.4 Astellas Pharma Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025)
11.5.5 Astellas Pharma Inc Recent Development
11.6 Gilead Sciences, Inc
11.6.1 Gilead Sciences, Inc Company Details
11.6.2 Gilead Sciences, Inc Business Overview
11.6.3 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Introduction
11.6.4 Gilead Sciences, Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025)
11.6.5 Gilead Sciences, Inc Recent Development
11.7 Novo Nordisk A/S (Xellia Pharmaceuticals)
11.7.1 Novo Nordisk A/S (Xellia Pharmaceuticals) Company Details
11.7.2 Novo Nordisk A/S (Xellia Pharmaceuticals) Business Overview
11.7.3 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Introduction
11.7.4 Novo Nordisk A/S (Xellia Pharmaceuticals) Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025)
11.7.5 Novo Nordisk A/S (Xellia Pharmaceuticals) Recent Development
11.8 Biosergen AB
11.8.1 Biosergen AB Company Details
11.8.2 Biosergen AB Business Overview
11.8.3 Biosergen AB Invasive Candidiasis Treatment Drug Introduction
11.8.4 Biosergen AB Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025)
11.8.5 Biosergen AB Recent Development
11.9 Matinas BioPharma Holdings, Inc
11.9.1 Matinas BioPharma Holdings, Inc Company Details
11.9.2 Matinas BioPharma Holdings, Inc Business Overview
11.9.3 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Introduction
11.9.4 Matinas BioPharma Holdings, Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025)
11.9.5 Matinas BioPharma Holdings, Inc Recent Development
11.10 Pulmocide Ltd
11.10.1 Pulmocide Ltd Company Details
11.10.2 Pulmocide Ltd Business Overview
11.10.3 Pulmocide Ltd Invasive Candidiasis Treatment Drug Introduction
11.10.4 Pulmocide Ltd Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025)
11.10.5 Pulmocide Ltd Recent Development
11.11 F2G Ltd
11.11.1 F2G Ltd Company Details
11.11.2 F2G Ltd Business Overview
11.11.3 F2G Ltd Invasive Candidiasis Treatment Drug Introduction
11.11.4 F2G Ltd Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025)
11.11.5 F2G Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Invasive Candidiasis Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Azoles Drug
Table 3. Key Players of Echinocandins Drug
Table 4. Key Players of Allylamines Drug
Table 5. Key Players of Polyenes Drug
Table 6. Key Players of Others
Table 7. Global Invasive Candidiasis Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Invasive Candidiasis Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Invasive Candidiasis Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Invasive Candidiasis Treatment Drug Market Share by Region (2020-2025)
Table 11. Global Invasive Candidiasis Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Invasive Candidiasis Treatment Drug Market Share by Region (2026-2031)
Table 13. Invasive Candidiasis Treatment Drug Market Trends
Table 14. Invasive Candidiasis Treatment Drug Market Drivers
Table 15. Invasive Candidiasis Treatment Drug Market Challenges
Table 16. Invasive Candidiasis Treatment Drug Market Restraints
Table 17. Global Invasive Candidiasis Treatment Drug Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Invasive Candidiasis Treatment Drug Market Share by Players (2020-2025)
Table 19. Global Top Invasive Candidiasis Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Candidiasis Treatment Drug as of 2024)
Table 20. Ranking of Global Top Invasive Candidiasis Treatment Drug Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Invasive Candidiasis Treatment Drug Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Invasive Candidiasis Treatment Drug, Headquarters and Area Served
Table 23. Global Key Players of Invasive Candidiasis Treatment Drug, Product and Application
Table 24. Global Key Players of Invasive Candidiasis Treatment Drug, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Invasive Candidiasis Treatment Drug Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Invasive Candidiasis Treatment Drug Revenue Market Share by Type (2020-2025)
Table 28. Global Invasive Candidiasis Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Invasive Candidiasis Treatment Drug Revenue Market Share by Type (2026-2031)
Table 30. Global Invasive Candidiasis Treatment Drug Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Invasive Candidiasis Treatment Drug Revenue Market Share by Application (2020-2025)
Table 32. Global Invasive Candidiasis Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Invasive Candidiasis Treatment Drug Revenue Market Share by Application (2026-2031)
Table 34. North America Invasive Candidiasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Invasive Candidiasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Invasive Candidiasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Invasive Candidiasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Invasive Candidiasis Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Invasive Candidiasis Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Invasive Candidiasis Treatment Drug Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Invasive Candidiasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Invasive Candidiasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 49. GlaxoSmithKline Company Details
Table 50. GlaxoSmithKline Business Overview
Table 51. GlaxoSmithKline Invasive Candidiasis Treatment Drug Product
Table 52. GlaxoSmithKline Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 53. GlaxoSmithKline Recent Development
Table 54. Merck & Co., Inc Company Details
Table 55. Merck & Co., Inc Business Overview
Table 56. Merck & Co., Inc Invasive Candidiasis Treatment Drug Product
Table 57. Merck & Co., Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 58. Merck & Co., Inc Recent Development
Table 59. Pfizer Inc Company Details
Table 60. Pfizer Inc Business Overview
Table 61. Pfizer Inc Invasive Candidiasis Treatment Drug Product
Table 62. Pfizer Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 63. Pfizer Inc Recent Development
Table 64. Cidara Therapeutics, Inc Company Details
Table 65. Cidara Therapeutics, Inc Business Overview
Table 66. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product
Table 67. Cidara Therapeutics, Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 68. Cidara Therapeutics, Inc Recent Development
Table 69. Astellas Pharma Inc Company Details
Table 70. Astellas Pharma Inc Business Overview
Table 71. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product
Table 72. Astellas Pharma Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 73. Astellas Pharma Inc Recent Development
Table 74. Gilead Sciences, Inc Company Details
Table 75. Gilead Sciences, Inc Business Overview
Table 76. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product
Table 77. Gilead Sciences, Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 78. Gilead Sciences, Inc Recent Development
Table 79. Novo Nordisk A/S (Xellia Pharmaceuticals) Company Details
Table 80. Novo Nordisk A/S (Xellia Pharmaceuticals) Business Overview
Table 81. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product
Table 82. Novo Nordisk A/S (Xellia Pharmaceuticals) Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 83. Novo Nordisk A/S (Xellia Pharmaceuticals) Recent Development
Table 84. Biosergen AB Company Details
Table 85. Biosergen AB Business Overview
Table 86. Biosergen AB Invasive Candidiasis Treatment Drug Product
Table 87. Biosergen AB Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 88. Biosergen AB Recent Development
Table 89. Matinas BioPharma Holdings, Inc Company Details
Table 90. Matinas BioPharma Holdings, Inc Business Overview
Table 91. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product
Table 92. Matinas BioPharma Holdings, Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 93. Matinas BioPharma Holdings, Inc Recent Development
Table 94. Pulmocide Ltd Company Details
Table 95. Pulmocide Ltd Business Overview
Table 96. Pulmocide Ltd Invasive Candidiasis Treatment Drug Product
Table 97. Pulmocide Ltd Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 98. Pulmocide Ltd Recent Development
Table 99. F2G Ltd Company Details
Table 100. F2G Ltd Business Overview
Table 101. F2G Ltd Invasive Candidiasis Treatment Drug Product
Table 102. F2G Ltd Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 103. F2G Ltd Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report


List of Figures
Figure 1. Invasive Candidiasis Treatment Drug Picture
Figure 2. Global Invasive Candidiasis Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Invasive Candidiasis Treatment Drug Market Share by Type: 2024 VS 2031
Figure 4. Azoles Drug Features
Figure 5. Echinocandins Drug Features
Figure 6. Allylamines Drug Features
Figure 7. Polyenes Drug Features
Figure 8. Others Features
Figure 9. Global Invasive Candidiasis Treatment Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Invasive Candidiasis Treatment Drug Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Invasive Candidiasis Treatment Drug Report Years Considered
Figure 15. Global Invasive Candidiasis Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Invasive Candidiasis Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Invasive Candidiasis Treatment Drug Market Share by Region: 2024 VS 2031
Figure 18. Global Invasive Candidiasis Treatment Drug Market Share by Players in 2024
Figure 19. Global Top Invasive Candidiasis Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Candidiasis Treatment Drug as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Invasive Candidiasis Treatment Drug Revenue in 2024
Figure 21. North America Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Invasive Candidiasis Treatment Drug Market Share by Country (2020-2031)
Figure 23. United States Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Invasive Candidiasis Treatment Drug Market Share by Country (2020-2031)
Figure 27. Germany Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Invasive Candidiasis Treatment Drug Market Share by Region (2020-2031)
Figure 35. China Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Invasive Candidiasis Treatment Drug Market Share by Country (2020-2031)
Figure 43. Mexico Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Invasive Candidiasis Treatment Drug Market Share by Country (2020-2031)
Figure 47. Turkey Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 51. Merck & Co., Inc Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 52. Pfizer Inc Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 53. Cidara Therapeutics, Inc Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 54. Astellas Pharma Inc Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 55. Gilead Sciences, Inc Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 56. Novo Nordisk A/S (Xellia Pharmaceuticals) Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 57. Biosergen AB Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 58. Matinas BioPharma Holdings, Inc Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 59. Pulmocide Ltd Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 60. F2G Ltd Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies